Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Sangamo Therapeutics, Inc
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Biological Products, (No Diagnostic Substances)
No intraday reading yet this session.
No case yet. It builds on the next filing, report or 13F period.
6 managers report a position worth $61,914 between them, and 2 of them hold 80% of it.
SGMOQ (Sangamo Therapeutics, Inc) has 0 disclosed suppliers and 4 disclosed customers, strongest disclosure first.
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
tall tick = annual report · 1 on record
Sangamo Therapeutics, Inc has no measured co-movers clearing our correlation floor, so only its SEC classification is shown.
SIC 2836, Biological Products, (No Diagnostic Substances), from each company's own filings. Largest first.